Multimodal therapy for urologic cancers

Bernard H Bochner and Peter T Scardino

doi:10.1038/ncpuro0583 | Full Text | PDF (77K)

An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated

Fiona C Burkhard, Martin C Schumacher and Urs E Studer

doi:10.1038/ncpuro0558 | Full Text | PDF (98K)

The case against extended lymph-node dissection for prostate cancer

Hartwig Huland

doi:10.1038/ncpuro0561 | Full Text | PDF (97K)

Intralesional IFN-2b benefits men with Peyronie's disease

doi:10.1038/ncpuro0565 | Full Text | PDF (103K)

Leak-point pressure might identify the predominant symptom in mixed incontinence

doi:10.1038/ncpuro0566 | Full Text | PDF (91K)

Pomegranate juice might delay recurrence of prostate cancer

doi:10.1038/ncpuro0567 | Full Text | PDF (100K)

New immunotherapy agent prolongs survival of men with advanced prostate cancer

doi:10.1038/ncpuro0568 | Full Text | PDF (103K)

Condom catheters are recommended for men without dementia

doi:10.1038/ncpuro0569 | Full Text | PDF (99K)

Pediatric detrusor overactivity can be treated with botulinum A toxin

doi:10.1038/ncpuro0570 | Full Text | PDF (102K)

Does Viagra^® improve lower urinary tract symptoms in men with erectile dysfunction?

doi:10.1038/ncpuro0571 | Full Text | PDF (89K)

Immediate androgen deprivation treatment beneficial in men with aggressive prostate cancer

doi:10.1038/ncponc0575 | Full Text | PDF (98K)

The urologist is a key determinant of ADT use in men with prostate cancer

doi:10.1038/ncpuro0572 | Full Text | PDF (112K)

Does cathelicidin have a role in the immune protection of the urinary tract?

doi:10.1038/ncpuro0573 | Full Text | PDF (89K)

Formalin instillation to treat hemorrhagic radiation proctopathy

doi:10.1038/ncpgasthep0569 | Full Text | PDF (95K)

IMP3: a new prognostic biomarker for renal-cell carcinoma?

doi:10.1038/ncponc0576 | Full Text | PDF (101K)

Testosterone therapy rebuilds muscle in older men

doi:10.1038/ncpendmet0248 | Full Text | PDF (102K)

Less postoperative pain with laparoscopic than with open donor nephrectomy

doi:10.1038/ncpneph0221 | Full Text | PDF (88K)

Can PSA nadir predict prostate cancer outcomes following radiotherapy?

Danny Y Song and Theodore L DeWeese

doi:10.1038/ncpuro0564 | Full Text | PDF (100K)

Does saturation biopsy improve prostate cancer detection?

Kihyuck Moon and Dan Theodorescu

doi:10.1038/ncpuro0552 | Full Text | PDF (97K)

The role of hormone replacement therapy in healthy elderly men

Paul J Jenkins

doi:10.1038/ncpuro0576 | Full Text | PDF (98K)

A combination of intravesical and BCG electromotive mitomycin for high-risk superficial bladder cancer

Ashish M Kamat and Colin PN Dinney

doi:10.1038/ncpuro0559 | Full Text | PDF (99K)

Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

Alexandre R Zlotta and Claude Schulman

doi:10.1038/ncpuro0579 | Full Text | PDF (98K)

Can preoperative administration of isosulfan blue improve outcomes of subinguinal varicocelectomy?

R Dale McClure

doi:10.1038/ncpuro0554 | Full Text | PDF (97K)

The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer

Kristin M Sanderson, Donald Skinner and John P Stein

doi:10.1038/ncpuro0582 | Full Text | PDF (185K)

Drug Insight: 5-reductase inhibitors for the treatment of benign prostatic hyperplasia

Michael Marberger

doi:10.1038/ncpuro0577 | Full Text | PDF (192K)